1. Prakash NJ, Schechter PJ, Grove J, Koch-Weser J. Effect of α-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice. Cancer Res 1978; 38: 3059–3062.
2. Freireich EJ, Frei E III, Karon M. Methylglyoxal bis-(guanylhydrazone): A new agent active against acute myelocytic leukemia. Cancer Chemother Rep 1962; 16: 183–186.
3. Kelsen D, Chapman R, Bains M, Heelan R, Dukeman M, Golbey R. Phase II study of methyl-GAG in the treatment of esophageal carcinoma. Cancer Treat Rep 1982; 66: 1427–1429.
4. Herr HW, Kleinert EL, Conti PS, Burchenal JH, Whitemore WF. Effects of α-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice. Cancer Res 1984; 44: 4382–4385.
5. Prakash NJ, Schechter PJ, Mamont PS, Grove J, Koch-Weser J, Sjoerdsma A. Inhibition of EMT6 tumor growth by interference with polyamine biosynthesis; Effects of α-difluoromethyl ornithine, an irreversible inhibitor of ornithine decarboxylase. Life Sci 1980; 26: 181–194.